2024 CME Information
3.75 Credits Available
1.25 CME Credits
May 30th, 2024, 9:30-10:45 am (EST)
“Cannabis, Endocannabinoids and PTSD”
– Dr. Matthew Hill
1.25 CME Credits
May 30th, 2024, 1:00-2:15 pm (EST)
“Using Laboratory Science to Inform Clinical Decision Making and Patient Safety in Medicinal Cannabis”
– Dr. Ryan Vandrey
1.25 CME Credits
May 31st, 2024, 8:15-9:30 am (EST)
“Cannabis Use Disorder”
– Dr. Margaret Haney
- Learning objectives: As a result of participation in this activity, participants will be able to learn about:
- Learn about using laboratory science to inform clinical decision making for patient safety in medicinal cannabis
- Learn about how cannabis effects the endocannabinoid system with particular focus on PTSD
- Learn about sex differences in symptoms of Cannabis Use Disorder
- Target audience: Primary care physicians and specialty physicians
- Accreditation statement: The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- Credit statement: The University of Florida College of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Commercial support (grant/exhibit) acknowledgement:
- This conference is supported by:
- Exhibits: FAMU Medical Marijuana Education and Research Initiative and OMMU (Office of Medical Marijuana Use)
- Grants: None
- Disclosure statement: No one in a position to control content has any financial relationships to disclose. Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure/. All relevant financial relationships have been mitigated.